Standard BioTools
LAB
LAB
80 hedge funds and large institutions have $106M invested in Standard BioTools in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.15% less ownership
Funds ownership: 92.9% → 89.74% (-3.2%)
31% less capital invested
Capital invested by funds: $154M → $106M (-$48.3M)
Holders
80
Holding in Top 10
1
Calls
$606K
Puts
$375K
Top Buyers
| 1 | +$1.62M | |
| 2 | +$628K | |
| 3 | +$361K | |
| 4 |
Millennium Management
New York
|
+$346K |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$345K |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$2.14M | |
| 3 | -$1.26M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$855K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$486K |